Form4insider filings, from the source

SEC Form 4 · accession 0001104659-17-069533

OCULAR THERAPEUTIX, INC · OCUL

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Amarpreet Sawhney
Officer — Exec. Chairman of the Board · Director · 10% Owner
Period of report
Nov 16, 2017
Accepted (ET)
Nov 20, 2017 · 8:04 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Nov 16, 2017P19,000$5.18A696,390D
Common StockF2holding———846,377ISee Footnote
Common StockF3holding———471,784ISee Footnote
Common StockF4holding———379,419ISee Footnote
Common StockF5holding———71,969ISee Footnote
Common StockF6holding———189,393ISee Footnote

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses

Remarks

Exhibit Index: 24.1 Power of Attorney